Thrombogenic properties of murine anti-cardiolipin antibodies induced by β2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies

Circulation

Volumn 94, Issue 7, 1996, Pages 1746-1751

  Pierangeli, Silvia S ^a   Liu, Xiao Wei ^b   Anderson, G ^c   Barker, J H ^c   Harris, E N ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

antibodies; anticoagulants; antigens; apolipoproteins; thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNIZATION; MALE; MOUSE; PRIORITY JOURNAL; THROMBOGENESIS;

EID: 10144232761     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1746     Document Type: Article

References (48)

1. Harris EN, Pierangeli SS. Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol. 1994;26: 223-245.
2. Lockshin MD. Amiphospholipid antibody syndrome. Rheum Dis Clin North Am. 1994;20:45-60.
3. Harris EN, Gharavi AE, Boey ML, Mackworth-Young CG, Patel BM, Loizou S, Hughes GRV. Anti-cardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211-1214.
4. Levine SR, Brey LR, Sawaya KL, Salowich-Palm L, Kokkinos J, Kostrzema B, Perry M, Haustad S, Carey J. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Ann Neurol. 1995;38:119-124.
5. The Antiphospholipid Antibodies and Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology. 1993;43:2069-2073.
6. Vaarala O, Mantarri M, Manninen V, Tenkanen L, Pauvunen M, Aho K, Palosuo T. Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation. 1995;91:23-27.
7. Kaplan SD, Chartash EK, Pizzarello RA, Furie RA. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J. 1992;124:1331-1338.
8. Miller DJ, Maisch SA, Perez MA, Kearney DL, Felters TF. Fatal myocardial infarction in an 8-year old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome. J Rheumatol. 1995;22:768-773.
9. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other antiphospholipid autoantibodies. Blood. 1994;84:2854-2867.
10. Branch DW, Dudley DJ, Mitchell MD. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol. 1990;163:210-216.
11. J. Piona A, Larosa L, Tincani A, Faen D, Magro G, Grasso S, Nicoletti F, Balestrieri G, Meroni PL. Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol. 1995;41:427-432.
12. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with mouse monoclonal and human polyclonal anticardiolipin antibodies. Proc Natl Acad Sci U S A. 1991;88:3069-3073.
13. Blank M, Tincani A, Shoenfeld Y. Induction of experimental antiphospholipid syndrome in naive mice with purified IgG antiphosphatidylserine antibodies. J Rheumatol. 1994;21: 100-104.
14. Suzuki T, Takabayashi K, Ichikawa K, Itou I, Ishiguro N, Yoshiki K, Koike T. Effects of monoclonal anticardiolipin antibody in pregnant mice. J Rheumatol. In press.
15. Bakimer R, Fishman P, Blank M, Srednc B, Djadeitti M, Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3) J Clin invest. 1992;89:1558-1563.
16. Blank M, Krause I, Ben-Bassat M, Shoenfeld Y. Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmun. 1992;5:495-509.
17. Sthoeger ZM, Tartakovsky B, Bentwich Z, Mozes E. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome. J Clin Immunol. 1993;13:127-138.
18. 2glycoprotein 1) induces experimental APS in na ive mice. Arthritis Rheum. 1993;36:S134. Abstract.
19. Pierangeli SS, Barker JH, Stikovac D, Anderson G, Ackerman D Barquinero J, Acland R, Harris EN. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Throm Haemost. 1994;71:670-674.
20. Pierangeli SS, Liu X, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunogloulins from patients with the antiphospholipid syndrome. Throm Haemost. 1995;74:1361-1367.
21. Galli M, Comfurius P, Maasen C, Heinker HC, deBaets MH, Val Breda Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Antica diolipin antibodies (ACA) are directed not to cardiolipin but to plasma protein cofactor. Lancet. 1990;336:1544-1547.
22. 2glycoprota 1 as an antigen. Br J Haematol 1992;81:568-573.
23. 2glycoprotei enhances cardiolipin binding activity but is not the target antigen antiphospholipid antibodies. Br J Haematol. 1992;82:565-570.
24. 2glycoprotein 1 ? J Lab Clin Med. 1993122:426-431.
25. 2glycoprotein l structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 1994;179:457-462.
26. 2glycoprotein l in the absence of phospholipid: importance of antigen density and bivalent binding. J Immunol. 1995;154:954-960.
27. 2glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA. 1990;87:4120-4124.
28. Harris EN, Pierangeli S. What is the 'true' antigen for antiphospholipid antibodies? Lancet. 1990;336:1550. Letter.
29. 2GP1). Clin Exp Immunol. 1995;102:373-378.
30. 2glycoprotein 1. J Clin Invest. 1992;90:1105-1109.
31. 2glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol. 1993;93:269-272.
32. 2glycoprotein 1-induced antiphospholipid antibodies. J Lab Clin Med. 1995;125:775-778.
33. 2glycoprotein 1 induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies. J Immunol. 1995;155: 958-966.
34. 2glycoprotein 1 in the rat: isolation from serum and demonstration in lipoprotein density fractions. Int J Biochem. 1979;11:265-270.
35. Stockmans F, Deckmyn H, Gruwez J, Vermylen J, Acland R. Continuous quantitative monitoring of mural thrombus kinetics in the crushed rat femoral vein. Thromb Haemost. 1991;65:425-431.
36. Cariou R, Tobelin G, Belluzi S, Soria J, Soria C, Maclouf J, Caen J. Effect of the lupus anticoagulant on antithrombogenic properties of endothelial cells: inhibition of thrombomodulin dependent protein C activation. Thromb Haemost. 1985;60:54-58.
37. Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, deGroot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism. Blood. 1993;81:2618-2625.
38. Smirnov MD, Triplett DT, Comp PC, Esmon ML, Esmon CT. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest. 1995;95:309-316.
39. Marciniak E, Romond EH. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood. 1989;74:2426-2432.
40. Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol. 1990;76:101-107.
41. 2glycoprotein 1. Br J Haematol. 1994;87:548-554.
42. Khamashta MA, Harris EN, Gharavi AE, Derue G, Hughes GRV. Immune mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis. 1988;47:849-854.
43. Martinuzzo MW, Maclouf J, Carreras LO, Levy-Toledano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemost. 1993;70:667-671.
44. Campbell AL, Pierangeli SS, Wellhausen S, Harris EN. Comparison of the effect of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation. Thromb Haemost. 1995;73:529-524.
45. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GRV, Zanussi C, Balestrieri G. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1988;74:247-252.
46. Branch DW, Rodgers GM. Induction of endothelial cell tissue factor activity by sera from patients with the antiphospholipid syndrome: a possible mechanism for thrombosis. Am J Obstet Gynecol. 1993;168:206-210.
47. 2GP1) does not cause fetal death. Am J Obstet Gynecol. 1995;173:1410-1415.
48. Smith HR, Hansen CL, Rose R, Canoso RT. Autoimmune MRL-1pr/ lpr mice are an animal model for the secondary antiphospholipid syndrome. J Rheumatol. 1990;17:911-915.